NOSOCOMIAL INFECTION RISK MONITORING

genetic PCR solutions™, registered trademark of the company Genetic Analysis Strategies S.L., is leading the project The Environmental Clinical Bio-safety System project: Nosocomial Infection Risk Monitoring, with the acronym NOSOBIOSAFE, wich intends to carry out planned research and critical studies aimed at developing and implementing a new system for rapid monitoring of microbial load, detection of nosocomial pathogens and their genetic profile of virulence and resistance to antibiotics in the air of hospital risk areas. In addition, this system will make it possible to predict outbreaks of new pathogens, even if they have not been previously described.

This research project is perfectly aligned with the challenges of the Strategic Innovation Committee (CEI) proposed in 2022, since the main objective is the prevention of infections caused by nosocomial pathogens and the development of early detection systems for colonizing microorganisms.

The NOSOBIOSAFE project has received a public grant for financial support from the Valencian Innovation Agency (AVI) within the Consolidation of the business value chain program (File No.: INNCAD/2022/23).